etoposide has been researched along with metribolone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, C; Uemura, H | 1 |
| Dimtchev, A; Dritschilo, A; Jung, M; Rosenthal, D; Smulson, M; Soldatenkov, V; Trofimova, I | 1 |
| Erbaykent-Tepedelen, B; Gonen-Korkmaz, C; Karamil, S; Korkmaz, KS | 1 |
3 other study(ies) available for etoposide and metribolone
| Article | Year |
|---|---|
Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment.
Topics: Androgens; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Northern; Calcimycin; Cell Survival; DNA-Binding Proteins; Etoposide; Humans; Male; Metribolone; Nuclear Receptor Subfamily 4, Group A, Member 1; Orchiectomy; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Receptors, Thyroid Hormone; Transcription Factors; Transfection | 1998 |
Gene therapy for prostate cancer by targeting poly(ADP-ribose) polymerase.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; DNA Damage; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Genetic Therapy; Humans; Male; Metribolone; Neoplasms, Hormone-Dependent; Plasmids; Poly(ADP-ribose) Polymerases; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Structure, Tertiary; Testosterone Congeners; Transfection; Tumor Cells, Cultured | 2002 |
DNA damage response (DDR) via NKX3.1 expression in prostate cells.
Topics: Acid Anhydride Hydrolases; Ataxia Telangiectasia Mutated Proteins; Camptothecin; Cell Cycle; Cell Line, Tumor; Cyclin D1; DNA Damage; DNA Repair; DNA Repair Enzymes; DNA-Activated Protein Kinase; DNA-Binding Proteins; Doxorubicin; Etoposide; Histones; Homeodomain Proteins; Humans; Hydrogen Peroxide; Irinotecan; Male; Metribolone; Mutagens; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Testosterone Congeners; Transcription Factors | 2014 |